Showing results (1-10 of 397) with videos related to
Sort By:
Pageof 40
Thrombosis Research|August 1, 1995
Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregabilityM Orth, C Luley, H WielandBiochimica Et Biophysica Acta|September 6, 1996
Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotypeM Orth, S Wahl, M Hanisch, et al.Clinical Chemistry|July 17, 1998
Fluorometric determination of total retinyl esters in triglyceride-rich lipoproteinsM Orth, M Hanisch, G Kröning, et al.European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|February 1, 1997
Diagnostic pitfalls during therapy for extreme hypertriglyceridaemiaM Orth, C LuleyClinical Chemistry and Laboratory Medicine|September 24, 1998
The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery diseaseJ Dierkes, E Bissé, M Nauck, et al.Journal of Lipid Research|May 1, 1991
Rapid apolipoprotein E phenotyping by immunofixation in agaroseC Luley, M W Baumstark, H WielandThrombosis Research|July 2, 1999
Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrateM Orth, H Mayer, M Halle, et al.The Journal of Automatic Chemistry|January 1, 1993
Analytical performance of the selective multianalyser Olympus AU 5200H Mayer, C Luley, M Behnke, et al.Clinical Biochemistry|August 28, 2001
An improved method for the rapid assessment of persisting chylomicron remnant concentrationsM Orth, C Weinland-Wilken, S Westphal, et al.The American Journal of Clinical Nutrition|March 25, 2000
Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acidsS Westphal, M Orth, A Ambrosch, et al.Pageof 40